Switching PD-1 to BRAF + MEK inhibition improves recurrence-free survival in patients receiving a second course of adjuvant melanoma therapy
将PD-1抑制剂替换为BRAF+MEK抑制剂可提高接受第二疗程辅助黑色素瘤治疗患者的无复发生存期。
期刊:Journal of the European Academy of Dermatology and Venereology
影响因子:8
doi:10.1111/jdv.20708
Schumann, Katharina; Klespe, Kai Christian; Mauch, Cornelia; Loquai, Carmen; Schultheis, Ulrike; Börger, Sevil; Thiem, Alexander; Emmert, Steffen; Hoellwerth, Magdalena; Kölblinger, Peter; Nguyen, Van Anh; Wanner, Marina; Richtig, Erika; Peitsch, Wiebke K; Harth, Wolfgang; Zenderowski, Veronika; Braun, Andreas Dominik; Mengoni, Miriam; Dummer, Reinhard; Mangana, Johanna; Maul, Lara Valeska; Meiß, Frank; Rappersberger, Klemens; Persa, Oana Diana; Biedermann, Tilo; Posch, Christian
